In a move to promote judicious use of water and an increased focus on demand side management, smart water meters will soon be introduced in nearly one lakh buildings across the city to track real-time ...

Bayer is suing insurance giant AIG, alleging decades-old insurance policies should have helped cover billions of dollars in legal costs from Roundup and PCB cases now being shouldered by the German ...

The Trump administration has urged the U.S. Supreme Court to hear Bayer's case aimed at stopping thousands of cancer lawsuits over its Roundup weedkiller. Bayer CEO Bill Anderson joined "The Claman ...

Bayer shares rose after the company said it welcomed the U.S. Solicitor General's support for a Supreme Court review of a case that could curtail longrunning litigation regarding its Roundup ...

Supreme Court effort comes as Bayer pushes Cancer Gag Act bills nationwide, to shield pesticide corporations from health-related lawsuits The Department of Justice has filed an amicus brief urging the ...

When Apple was still in the Lightning era and fought tooth and nail against USB-C, the common argument was that Lightning ports were significantly thinner than their USB-C alternatives. The USB-C ...

Bayer stock jumped on Monday after the German healthcare company said a late-stage stroke drug trial achieved its goals, a development that also helped a rival creating a competing drug. Bayer didn’t ...

Bayer’s oral FXIa inhibitor asundexian has significantly reduced the risk of stroke in a phase 3 trial, giving a boost to a potentially blockbuster mechanism that has suffered setbacks over the past ...

A Bayer drug designed to target tumors driven by a rare genetic mutation now has accelerated FDA approval, providing another treatment option for certain patients with advanced cases of lung cancer.

Bayer has cleared out four cancer candidates from its early-stage pipeline, including a STAT3 inhibitor acquired as part of its buyout of Vividion Therapeutics. The Vividion asset in question, called ...

The US Food and Drug Administration has approved another once-a-day pill that works without hormones to treat moderate to severe hot flashes in menopausal women, drugmaker Bayer said Friday. The drug, ...